Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1988 1
1989 1
1992 1
1994 3
1996 1
2005 2
2008 2
2009 1
2010 3
2011 2
2013 1
2014 1
2015 2
2016 2
2018 1
2019 1
2020 2
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Results by year
Filters applied: . Clear all
Page 1
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.
Lozano AX, Chaudhuri AA, Nene A, Bacchiocchi A, Earland N, Vesely MD, Usmani A, Turner BE, Steen CB, Luca BA, Badri T, Gulati GS, Vahid MR, Khameneh F, Harris PK, Chen DY, Dhodapkar K, Sznol M, Halaban R, Newman AM. Lozano AX, et al. Among authors: harris pk. Nat Med. 2022 Feb;28(2):353-362. doi: 10.1038/s41591-021-01623-z. Epub 2022 Jan 13. Nat Med. 2022. PMID: 35027754 Free PMC article.
Commercial ctDNA Assays for Minimal Residual Disease Detection of Solid Tumors.
Chen K, Shields MD, Chauhan PS, Ramirez RJ, Harris PK, Reimers MA, Zevallos JP, Davis AA, Pellini B, Chaudhuri AA. Chen K, et al. Among authors: harris pk. Mol Diagn Ther. 2021 Nov;25(6):757-774. doi: 10.1007/s40291-021-00559-x. Epub 2021 Nov 1. Mol Diagn Ther. 2021. PMID: 34725800 Review.
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
Chauhan PS, Chen K, Babbra RK, Feng W, Pejovic N, Nallicheri A, Harris PK, Dienstbach K, Atkocius A, Maguire L, Qaium F, Szymanski JJ, Baumann BC, Ding L, Cao D, Reimers MA, Kim EH, Smith ZL, Arora VK, Chaudhuri AA. Chauhan PS, et al. Among authors: harris pk. PLoS Med. 2021 Aug 31;18(8):e1003732. doi: 10.1371/journal.pmed.1003732. eCollection 2021 Aug. PLoS Med. 2021. PMID: 34464379 Free PMC article.
Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.
Szymanski JJ, Sundby RT, Jones PA, Srihari D, Earland N, Harris PK, Feng W, Qaium F, Lei H, Roberts D, Landeau M, Bell J, Huang Y, Hoffman L, Spencer M, Spraker MB, Ding L, Widemann BC, Shern JF, Hirbe AC, Chaudhuri AA. Szymanski JJ, et al. Among authors: harris pk. PLoS Med. 2021 Aug 31;18(8):e1003734. doi: 10.1371/journal.pmed.1003734. eCollection 2021 Aug. PLoS Med. 2021. PMID: 34464388 Free PMC article.
Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.
Chaudhuri AA, Pellini B, Pejovic N, Chauhan PS, Harris PK, Szymanski JJ, Smith ZL, Arora VK. Chaudhuri AA, et al. Among authors: harris pk. JCO Precis Oncol. 2020 Jul 15;4:PO.20.00060. doi: 10.1200/PO.20.00060. eCollection 2020. JCO Precis Oncol. 2020. PMID: 32923907 Free PMC article. Review. No abstract available.
ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine.
Pellini B, Pejovic N, Feng W, Earland N, Harris PK, Usmani A, Szymanski JJ, Qaium F, Mudd J, Petty M, Jiang Y, Singh A, Maher CA, Henke LE, Park H, Ciorba MA, Kim H, Mutch MG, Pedersen KS, Tan BR, Hawkins WG, Fields RC, Chaudhuri AA. Pellini B, et al. Among authors: harris pk. JCO Precis Oncol. 2021 Feb 12;5:PO.20.00276. doi: 10.1200/PO.20.00276. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34250420 Free PMC article.
Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study.
Chauhan PS, Chen K, Babbra RK, Feng W, Pejovic N, Nallicheri A, Harris PK, Dienstbach K, Atkocius A, Maguire L, Qaium F, Szymanski JJ, Baumann BC, Ding L, Cao D, Reimers MA, Kim EH, Smith ZL, Arora VK, Chaudhuri AA. Chauhan PS, et al. Among authors: harris pk. PLoS Med. 2021 Dec 14;18(12):e1003876. doi: 10.1371/journal.pmed.1003876. eCollection 2021 Dec. PLoS Med. 2021. PMID: 34905549 Free PMC article.
Cell-free DNA alterations in the AR enhancer and locus predict resistance to AR-directed therapy in patients with metastatic prostate cancer.
Dang HX, Chauhan PS, Ellis H, Feng W, Harris PK, Smith G, Qiao M, Dienstbach K, Beck R, Atkocius A, Qaium F, Luo J, Michalski JM, Picus J, Pachynski RK, Maher CA, Chaudhuri AA. Dang HX, et al. Among authors: harris pk. JCO Precis Oncol. 2020;4:680-713. doi: 10.1200/po.20.00047. Epub 2020 Jun 18. JCO Precis Oncol. 2020. PMID: 32903952 Free PMC article.
35 results